Preclinical Evaluation of the Third-Generation, Bi-Steric Mechanistic Target of Rapamycin Complex 1-Selective Inhibitor RMC-6272 in NF2-deficient Models.
Neuro-Oncology Advances（2024）
Key words
4E-BP1,meningioma,mTORC1,NF2,RMC-6272
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined